In the human brain, DAAO is suggested to be involved in the central nervous system and its related disorders, such as schizophrenia and amyotrophic lateral sclerosis (ALS), through the metabolism of d-Ser, which is a co-agonist of the N-methyl d-aspartate receptor4–7. The gene discussed is DAO; the disease is amyotrophic lateral sclerosis.